The discovery of antidepressant drugs led to the first biochemical hypothesis of depression, known as the monoamine hypothesis. However, this hypothesis does not seem to fully explain the complexity of human depression. Now a new study offers one more important key that may increase our understanding of the pathogenesis behind clinical depression and neurodegenerative disorders.